Meta-analyses indicate that the gene coding for the dopamine transporter (DAT1 or SLC6A3) is associated with an increased risk for ADHD. The mechanisms of this gene for ADHD are unclear. We systematically reviewed studies linking the VNTR in the 3 0 UTR of the DAT1 to neurophysiological and neuropsychological measures. In addition, a broad set of executive/cognitive and motor tests was administered to 350 children (5-11 years) and adolescents (11-19 years) with ADHD and 195 non-affected siblings. Two VNTRs (in intron 8 and the 3 0 UTR) and four SNPs (two 5 0 and two 3 0 ) in DAT1 were genotyped. The effect of the polymorphisms on neuropsychological functioning was studied. The review indicated that the majority of studies did not find a relation between DAT1 and neurophysiological or neuropsychological measures. In our sample, several of the polymorphisms of DAT1 were associated with ADHD and ADHD was associated with impaired neuropsychological functioning. However, none of the DAT1 polymorphisms was convincingly associated with neuropsychological dysfunctioning. This suggests that the effect of DAT1 on ADHD was not mediated by neuropsychological performance. However, since DAT1 is mainly expressed in the striatum and not the prefrontal cortex, it may influence striatum-related functions (such as delay aversion) more heavily than prefrontal related functions (such as executive functions). Associations of DAT1 with ADHD were only found in adolescents, which may suggest that DAT1 mainly exerts its effect in adolescence, and/or that having a more persistent form of ADHD may mark a more severe or homogeneous genetic form of the disorder.
Meta-analyses indicate that the gene coding for the dopamine transporter (DAT1 or SLC6A3) is associated with an increased risk for ADHD. The mechanisms of this gene for ADHD are unclear. We systematically reviewed studies linking the VNTR in the 3 0 UTR of the DAT1 to neurophysiological and neuropsychological measures. In addition, a broad set of executive/cognitive and motor tests was administered to 350 children (5-11 years) and adolescents (11-19 years) with ADHD and 195 non-affected siblings. Two VNTRs (in intron 8 and the 3 0 UTR) and four SNPs (two 5 0 and two 3 0 ) in DAT1 were genotyped. The effect of the polymorphisms on neuropsychological functioning was studied. The review indicated that the majority of studies did not find a relation between DAT1 and neurophysiological or neuropsychological measures. In our sample, several of the polymorphisms of DAT1 were associated with ADHD and ADHD was associated with impaired neuropsychological functioning. However, none of the DAT1 polymorphisms was convincingly associated with neuropsychological dysfunctioning. This suggests that the effect of DAT1 on ADHD was not mediated by neuropsychological performance. However, since DAT1 is mainly expressed in the striatum and not the prefrontal cortex, it may influence striatum-related functions (such as delay aversion) more heavily than prefrontal related functions (such as executive functions). Associations of DAT1 with ADHD were only found in adolescents, which may suggest that DAT1 mainly exerts its effect in adolescence, and/or that having a more persistent form of ADHD may mark a more severe or homogeneous genetic form of the disorder.
INTRODUCTION
Attention-Deficit/Hyperactivity Disorder (ADHD) [American psychiatric Association, 1994 ] is strongly heritable. Based on the results of multiple twin studies conducted worldwide, ADHD has an estimated heritability of approximately 76% [Faraone et al., 2005] . Several reviews and meta-analyses have been published on the involvement of dopaminergic genes in ADHD [Swanson et al., 2000; Curran et al., 2001; Faraone et al., 2001 Faraone et al., , 2005 Maher et al., 2002; Li et al., 2006; Yang et al., 2007] . Most meta-analyses have shown evidence for the involvement of genes coding for dopamine receptors 4 and 5 (DRD4 and DRD5, respectively), the gene encoding for the dopamine transporter (DAT1 or SLC6A3), and the gene coding for the enzyme dopamine beta-hydroxylase (DBH) [Faraone et al., 2005] . We focus here on the role of the DAT1 gene in ADHD, since it is one of the most studied genes in ADHD [Thapar et al., 2005] .
DAT1 is located on chromosome 5p15.3. The most widely studied polymorphism is a 40 base pair variable number of tandem repeats (VNTR) polymorphism located in the 3 0 untranslated region (UTR) of the gene [Maher et al., 2002; Faraone et al., 2005; Yang et al., 2007] . The number of repeats ranges between 3 and 13 [Vandenbergh et al., 1992; Nakatome et al., 1996] , with 10 and 9, respectively, being the most common [Mitchell et al., 2000] . Although this polymorphism is not located in a translated region of the gene, it may have an effect on gene expression [Mill et al., 2002] . This has been investigated in vitro as well as in vivo, with conflicting results [Madras et al., 2005; Brookes et al., 2007] . It has been suggested that the 10-repeat allele is associated with an abnormally active dopamine transporter, resulting in an increased re-uptake of dopamine and thus in a depletion of dopamine in the synaptic cleft [Mill et al., 2002] . This may lead to hypoactivity of the dopaminergic pathways [Yang et al., 2007] . DAT1 is mainly expressed in the striatum and to a lesser extent in the prefrontal cortex [Diamond, 2007] . Eliminating DAT1 gene function in mice increases hyperactivity and disinhibition [Giros et al., 1996] . However, the exact mechanisms of the DAT1 effect on ADHD pathology remain unclear. Several studies have tried to unravel the modes of action of DAT1 by studying the association of the gene with neurophysiological and neuropsychological measures. Neurophysiological and neuropsychological measures may function as endophenotypes (intermediate phenotypes): heritable, underlying, continuously distributed traits that heighten the risk for developing a disorder and mediate between genotype and phenotype [Gottesman and Gould, 2003] . Endophenotypes are proposed to be more heritable than phenotypes because they are etiologically ''closer'' to the disease genes than phenotypes and offer the advantage of a quantitative trait instead of dichotomous entities like DSM diagnostic categories [Gottesman and Gould, 2003] . Therefore, focusing on neurophysiological and neuropsychological measures in relation to DAT1 in ADHD may provide insight into the pathways leading from DAT1 to ADHD.
Review of Studies Linking DAT1 to Neurophysiological and Neuropsychological Measures
An overview of the studies cited here is provided in Table I . Most studies have compared the 10/10 genotype of the 3 0 UTR VNTR with the 9/10 and 9/9 genotypes. The results are inconsistent and tend to suggest no significant association of the VNTR with neurophysiological and neuropsychological measures. With respect to IQ, one study reported that the 10/10 genotype was associated with a lower IQ in two independent samples of ADHD children, but not in controls, suggesting a common genetic basis for ADHD and low IQ [Mill et al., 2006] . However, this finding has not been replicated by a study using a substantially larger sample of ADHD children and their nonaffected siblings nor in a study of affected sib-pairs from 251 families [Sonuga-Barke et al., 2008; Loo et al., submitted] . Three other studies using non-ADHD subjects found no relation between DAT1 and IQ either [Ball et al., 1998; Rueda et al., 2005; Genro et al., 2006] . Therefore, most studies suggest no relation between DAT1 and IQ.
The three largest studies (N ¼ 540, N ¼ 146, and N ¼ 122) exploring several neuropsychological functions (attention and several executive functions) in relation to DAT1 in ADHD found no or only few associations [Barkley et al., 2006; Wohl et al., 2008; Loo et al., submitted] . No differences were reported in the largest study between ADHD adolescents and adults with the 10/10 genotype and ADHD adolescents and adults with the 9/10 genotype on 14 of 15 variables [Barkley et al., 2006] . On one variable of inhibition, the 10/10 genotype performed more poorly than the 9/10 genotype. The second largest study did not find differences between the 10 allele and 9 allele on measures of inhibition and cognitive flexibility [Wohl et al., 2008] . The other study did not find any differences between carriers of the 10/10 genotype and others on 14 of 14 variables, except for one interaction (10/10 in combination with ADHD in the mother related to poorer set-shifting) [Loo et al., submitted] . Several other studies, utilizing substantially smaller samples (N < 100), also reported mainly negative results. One study found no effect of DAT1 on 10 of 10 working memory variables, though the 10/10 genotype appeared related to poorer (selective) attention (1 of 4 measures) and inhibition (1 of 1 measure) [Cornish et al., 2005] . Furthermore, no relation was found between DAT1 and 24 of 25 variables measuring several executive and non-executive functions, except for 1 of 4 measures of inhibition: Adults with the 10/10 genotype contrarily displayed a better inhibition than adults with other genotypes [Boonstra et al., 2007] . Negative or contrary findings were also reported in two other studies, who found no effects of DAT1 on 2 of 3 measures of vigilance and 15 of 16 measures of attention, except for the one finding that individuals with the 10/10 genotype committed fewer errors than individuals with the 9/10 and 9/9 genotype and less omission errors in the first quarter of a test of attention [Oh et al., 2003; Kim et al., 2006] . In addition, no differences were reported between the 10/10 genotype and other genotypes for regional blood flow during a vigilance task [Szobot et al., 2005] .
Similar negative or contrary findings were found when the effect of DAT1 (10/10 vs. other genotypes) was studied in healthy individuals. One study found no effect on 4 of 4 measures of attention [Fossella et al., 2002] ; another study found no effect on 8 of 8 measures of episodic memory, although the 10/10 genotype had less midbrain activation during task performance [Schott et al., 2006] ; another study found no effect on 2 of 4 measures of attention and a reversed effect on the other 2 (10/10 performing better on a conflict task and showing stronger ERPs) [Rueda et al., 2005] ; another study found no effect of DAT1 on ERPs (except for a stronger gamma response to target stimuli in 10/10 genotype controls) [Demiralp et al., 2007] .
The findings reported above suggest that DAT1 is not associated with neuropsychological and neurophysiological abnormalities frequently reported in ADHD. However, some studies did report a relation of DAT1 with these measures. In two studies, the same authors found that ADHD children with the 10/10 genotype displayed an abnormal reduction in attentional asymmetry (i.e., reduced leftward inattention) and increased response variability compared to affected children with other genotypes [Bellgrove et al., 2005a,b] . The same authors also reported that normal children with the 10/10 genotype (or the 3/3 (now called 6/6) genotype in intron 8 which is in moderate linkage disequilibrium with the VNTR in the 3 0 UTR) displayed inattention for left-sided stimuli [Bellgrove et al., 2007] . Other researchers found abnormalities in vigilance and EEG activity in response to methylphenidate in ADHD affected children with the 10/10 genotype [Loo et al., 2003] . In addition, one study reported that the 10/10 genotype had no effect on performance on an inhibition task in children with ADHD, their non-affected siblings and controls, yet the 10/10 genotype was associated with lower activation patterns in the striatum during the task in children with ADHD and their non-affected siblings, but not controls [Durston et al., 2008] . The authors suggest that DAT1 gene effects in the striatum may be involved in translating the genetic risk of ADHD into a neurobiological substrate.
Although the majority of studies report no effects of DAT1 on neurophysiological and neuropsychological measures, methodological aspects may have contributed significantly to the observed pattern of results. For example, differences in ascertainment (different ADHD subtypes, including controls or not), differences in ADHD measurement methods (interview of questionnaires), sampling (clinically referred or not), participants characteristics (such as age, sex, and comorbidity) and the focus on a single polymorphism are plausibly related to null effects. Given that some effects of DAT1 on neurophysiological and neuropsychological measures have been found, further research is needed to understand the nature and extent of these effects.
Current Study on the Relation Between DAT1 and Neuropsychological Measures in ADHD
We sought to improve upon previous studies described above in several respects. First, we recruited a large sample of ADHD subjects (N ¼ 350). Most previous studies have utilized much smaller samples, increasing the chance of obtaining spurious results. We further extended our sample with 195 non-affected siblings of ADHD children. Second, we analyzed the effect of DAT1 separately for children and adolescents, since we expected to find stronger effects of DAT1 in adolescents. Levels of dopamine decrease with age and the effect of the DAT1 10/10 vs. 9/10 and 9/9 In both independent samples, 10/10 lower IQ, but only in ADHD subjects and not in controls [Barkley et al., 2006] . For example, one study reported that the effects of DAT1 on phenotypical measures of ADHD were stronger, when the longitudinally followed sample was studied in adolescence and adulthood compared to childhood [Barkley et al., 2006] . Third, we applied a broad neuropsychological battery covering not only executive/cognitive functions, but also motor functions. Previous studies have shown that DAT1 mainly effects dopamine neurotransmission in the basal ganglia and midbrain, but less in the prefrontal cortex [Durston et al., 2005; Schott et al., 2006; Diamond, 2007; Scherk et al., 2007] . Therefore, we expected that the effect of DAT1 was on motor measures and not (or to a lesser extent) on executive/cognitive measures. Fourth, almost all previous studies except two have studied only the effect of the VNTR in the 3 0 UTR of DAT1 [Bellgrove et al., 2007; Sonuga-Barke et al., 2008] . Although this polymorphism may influence gene expression [Mill et al., 2002] , this is not a well established finding [Thapar et al., 2005; Brookes et al., 2007] . The VNTR in the 3 0 UTR may also be in linkage disequilibrium with the true functional polymorphism [Brookes et al., 2006; Asherson et al., 2007] . Therefore, we applied a more thorough investigation of the DAT1 effect on neuropsychological measures, by genotyping 6 polymorphisms (VNTR in the 3 0 UTR, VNTR in intron 8, 2 SNPs in the 5 0 flanking region, 1 SNP in intron 10 and 1 SNP in intron 13). Two haplotypes (combination of alleles transmitted together) were formed, one from the VNTRs, one from the SNPs, which allowed for robust analyses of the DAT1 effect, since the haplotypes might tag other variants that are not directly tested [Sklar, 2005] and may be more strongly associated with disease or trait than individual polymorphisms [Barr et al., 2001] .
In order to examine the neuropsychological mechanisms of DAT1 in ADHD, we first confirmed the association between polymorphisms in DAT1 with ADHD diagnosis in our sample. The association between ADHD diagnosis and neuropsychological dysfunction was confirmed [Rommelse et al., 2007a [Rommelse et al., ,b,c, 2008a . Thereafter, we went on to examine the association between risk polymorphisms in DAT1 and neuropsychological dysfunctions.
MATERIALS AND METHODS

Subjects
Participants were recruited through child psychiatric clinics in the Dutch part of the International Multicenter ADHD Genetics (IMAGE) study that aims to identify genes that increase the risk for ADHD using QTL linkage and association strategies [Brookes et al., 2006] Rommelse et al., 2007b] . All subjects were between the ages of 5 and 19 years old and were of European Caucasian descent. Participants were excluded, if they had an IQ < 70, a diagnosis of autism, epilepsy, brain disorders or known genetic disorders, such as Down syndrome or Fragile-X-syndrome.
The screening procedures and measures for phenotyping have been described previously [Brookes et al., 2006; Lasky-Su et al., 2007] . Briefly, screening questionnaires (parent and teacher Conners' long version rating scales [Conners, 1996] and parent and teacher Strengths and Difficulties Questionnaires [Goodman, 1997] ) were used to identify subjects with ADHD symptoms. Scores were considered clinical if T-scores on Conners' ADHD-subscales (DSM-IV Inattention, DSM-IV Hyperactive-Impulsive, and DSM-IV ADHD Total) were 63 or scores on the SDQ-hyperactivity scale were >90th percentile. Additionally, the Parental Account of Children's Symptoms (PACS) [Taylor, 1986] was administered to subjects scoring clinically on any of the questionnaires. Impairment was determined as significant if functioning was impaired in home situations and/or at school. For diagnostic purposes, data of the questionnaires and the PACS were subjected to a standardized algorithm to derive each of the 18 DSM-IV ADHD symptoms, providing operational definitions for each behavioral symptom [Rommelse et al., 2007a] .
Neuropsychological Tasks
The ten neuropsychological tasks used in this study have been described and analyzed elsewhere [Rommelse et al., 2007a [Rommelse et al., ,b,c, 2008a and are presented in Table II . Missing data was less than 5% for all variables, except for the Stop task (9%). Based on previous results [Rommelse et al., 2007a [Rommelse et al., ,b,c, 2008a , the variable for each task, which showed the most optimal results in the endophenotypic analyses, was chosen for Full description of the tasks can be found in Rommelse et al. 2007a Rommelse et al. ,b,c, 2008a .
analysis. All variables were normalized and standardized using a Van der Waerden transformation (Statistical Package for the Social Sciences version 14). To obtain a robust measure of overall neuropsychological functioning with less error variance than the individual task measures, a principal component analysis was performed on the ten task variables. All ten task measures related to one major component, explaining 47% of the variance in the task measures [see Rommelse et al. 2008c for more detail].
DNA Extraction and DAT1 Genotyping
An elaborate description of DNA extraction and (DAT1) genotyping is provided elsewhere [Brookes et al., 2006] . Briefly, DNA was extracted directly from blood samples or cell lines at Rutgers Cell line and DNA repository in the US. Two VNTRs and four single nucleotide polymorphisms (SNPs), which had been genotyped in earlier studies in the IMAGE sample and had shown association with ADHD in this sample were selected for the current study [Brookes et al., 2006; Asherson et al., 2007] . The two VNTRs (40 bp VNTR in the 3 0 UTR and 30 bp VNTR in intron 8) had been genotyped in a sample of 1168 IMAGE families, which included 220 of the Dutch families that were part of the current study. Genotyping had been performed using standard polymerase chain reaction (PCR) protocols and visualization of amplified products on 2% agarose gels as described before [Brookes et al., 2005] . The four SNPs (rs2550946, rs11564750, rs3776513, and rs40184) had been genotyped in a sample of 1050 IMAGE families, including 184 Dutch families from this study. Genotyping had been done using the Illumina Golden Gate Assay TM (Illumina, Inc., San Diego, CA) [Brookes et al., 2006] , ABI SNPlex (rs3776513) [Tobler et al., 2005] and ABI TaqMan (rs2550946, rs11564750, and rs40184) genotyping platforms (Applied Biosystems, Foster City, CA) [for more details see Brookes et al., 2008] . See Figure 1 for linkage disequilibrium between the polymorphisms. VNTR genotypes were available for 89.3% of the subjects and we estimated the missing genotypes using haplo.stats [Sinnwell and Schaid, 2005] . Briefly, haplo.stats estimates haplotype frequencies and posterior probabilities of haplotype pairs for a subject, conditional on the observed marker data [Schaid et al., 2002] . Eight different VNTR haplotypes were present in the sample based on the VNTR in the 3 0 UTR and the VNTR in intron 8 (Table III) . The risk 10-6_10-6 diplotype was present in 52.5% of the sample. A diplotype was defined as a pair of haplotypes from a given participant: one haplotype received from each parent. Thus, a participant has only one diplotype. Genotypes of all four SNPs were available for 344 subjects (63.1%). Since the proportion of missing genotypes may increase with the number of SNPs available in our data set, we decided not to estimate missing data for this set of markers given the fact that the posterior probability for a genotype may be greatly reduced. Twelve different SNP haplotypes were found in the sample based on two SNPs in the 5 0 flanking region, one SNP in intron 10 and one SNP in intron 13 (Table III) . The haplotype which had increased the risk for ADHD in an earlier study (XXGC_XXGC) was present in 25.6% of the sample. 
Data Analysis
Hardy-Weinberg equilibrium (HWE) proportions were estimated from parental DAT1 genotype information using the Markov-Chain Monte-Carlo approximation of the exact test implemented in the GENEPOP package V 3.3 [Raymond and Rousset, 1995] . No deviations from HWE were detected for any of the polymorphisms (df ¼ 2, P values between 0.061 and 0.500).
Association tests for the single markers were based on comparison of the risk genotype with a group consisting of all other genotypes. For this, the risk haplotype was defined as the genotype that had shown association with ADHD in earlier studies with a group of all other genotypes [Brookes et al., 2006 Asherson et al., 2007] . In order to test the association between DAT1 and ADHD in our sample, we analyzed whether affected and non-affected siblings differed in proportions of risk and non-risk genotypes on the six individual markers and in the proportion of risk and non-risk diplotype transmission using w 2 comparisons. The association between ADHD and poor neuropsychological test performance was analyzed using linear mixed models with diagnosis as between group factor, age as covariate, and family structure as random effect to account for within family correlation [Rommelse et al., 2007a [Rommelse et al., ,b,c, 2008a . An aggregated neuropsychological component was used as dependent measure of overall neuropsychological functioning.
The association of DAT1 with neuropsychological performance was analyzed using a linear mixed model with DAT1 as factor (risk vs. non-risk genotypes/diplotypes), age as covariate, and family structure as random effect. The aggregated neuropsychological component was used as dependent measure.
All analyses were conducted first for all participants, and repeated after splitting the sample by median age (children <11.5 years and adolescents >11.5 years), since previous studies had shown that the relation of genetic risk markers with neuropsychological functioning as well as ADHD diagnosis is not constant across age [Barkley et al., 2006; Elia and Devoto, 2007] . Correction for multiple comparisons according to the False Discovery Rate (FDR) controlling procedure was applied to the analyses with a q-value setting of 0.05 [Benjamini and Hochberg, 1995] .
RESULTS
Association of DAT1 With ADHD Diagnosis
As shown in Table IV , significant findings were restricted to the adolescent sample after correction for multiple testing: three single risk markers (10/10 genotype in 3 0 UTR VNTR, GG in intron 10 and CC in intron 13) and both risk diplotypes (10-6_10-6 and XXGC_XXGC) were more common in affected adolescents compared to non-affected adolescents. Also, the co-occurrence of the two risk diplotypes together was more common in affected than in non-affected adolescents (Table IV) , which was at least partly due to the linkage disequilibrium between the VNTRs and the 3 0 SNPs (Fig. 1) .
Association of ADHD Diagnosis With Neuropsychological Performance
As previously reported [Rommelse et al., 2007a [Rommelse et al., ,b,c, 2008a , affected siblings also performed more poorly on the neuropsychological tasks than their non-affected siblings (F (1, 329.4) ¼ 32.90, P < 0.001). This result was robust, when analyses were repeated for children and adolescents, separately (F (1, 196 .0) ¼ 21.54, P < 0.001 and F (1,190.7) ¼ 23.00, P < 0.001), indicating ADHD diagnosis to be associated with poorer neuropsychological performance within families. P values are one-sided. Significant findings corrected for multiple testing in bold.
Association of DAT1 With an Aggregated Neuropsychological Measure
As shown in Table V, no effect on neuropsychological performance was found for any of the single markers or diplotypes, neither in the whole sample nor in the separate analyses in children or adolescents. Thus, the single markers and diplotypes that showed association with the ADHD diagnosis in adolescents were not related to impaired neuropsychological functioning. Moreover, the siblings with the highest possible risk (those with both risk diplotypes) did not differ from other siblings in neuropsychological performance.
Additional Analyses
A clear pattern of results emerged: DAT1 was associated with ADHD, ADHD was associated with impaired neuropsychological performance, but DAT1 was not associated with impaired neuropsychological performance. To further substantiate these findings, we sought to reject the hypothesis that we missed a relationship between DAT1 and neuropsychological performance due to three possibilities.
Possibility 1: DAT1 is only associated with specific neuropsychological measures and not an overall neuropsychological measure. If DAT1 were associated with specific neuropsychological functions, the overall measure we used might have clouded this relation. Therefore, we repeated the analyses, as described above, for each of ten neuropsychological measures. An additional 270 statistical tests were performed. Of the 90 statistical tests in the entire sample, only two were nominally significant, which is a finding one would expect to find by chance and did not survive multiple testing. Interestingly, though, the two tests showed similar results: a risk genotype (6/6 in intron 8), and the combination of risk diplotypes (10-6_10-6 with XXCG_XXCG) were associated with increased variability of motor timing (F (1, 470.7) ¼ 4.63, P ¼ 0.03; F (1, 322.0) ¼ 4.60, P ¼ 0.03). In the child subsample, also only two of 90 statistical tests were nominally significant and did not survive multiple testing correction: one risk marker (SNP rs3776513 in intron 10) was associated with a poorer neuropsychological score (Tapping: F (1, 159.0) ¼ 4.55, P ¼ 0.04), another risk marker (SNP rs2550946 in the 5 0 flanking region) was associated with a better neuropsychological score (Motor Timing: F (1, 143.9) ¼ 5.48, P ¼ 0.02). In the adolescent subgroup, two significant and six nominally significant associations emerged. Two of these six findings were described above (i.e., risk markers associated with increased motor timing variability, P values in the adolescent subsample were 0.007 [significant] and 0.04, respectively).
Three of the other four associations were for a DAT1 marker (SNP rs11564750 in the 5 0 flanking region) that had not shown association with ADHD in adolescents (Pursuit: F (1, 167.4) ¼ 4.42, P ¼ 0.04; Tracking: F (1, 174.2) ¼ 8.43, P ¼ 0.004 [significant]; Motor Timing: F (1, 143.4) ¼ 4.20, P ¼ 0.04). Therefore, these associations do not shed light on the function of DAT1 in relation to ADHD. The other nominally significant finding was for the GG genotype in intron 10 and poorer accuracy in Tracking (F (1, 174. 3) ¼ 4.15, P ¼ 0.04). The results indicate a lack of association between DAT1 and an aggregated neuropsychological factor was most likely not due to a specific relation between DAT1 and a neuropsychological functioning that was overlooked in the former analyses.
Possibility 2: DAT1 is only associated with neuropsychological performance in non-affected siblings and not in affected siblings. The non-significant relation between DAT1 and overall neuropsychological functioning may be attributable to a differential effect of DAT1 on neuropsychological functioning in affected and non-affected subjects. We reasoned that the effect of a gene may be more purely studied in non-affected siblings than in affected subjects, since this latter group may have accumulated so many risk genes and risk environmental factors that the (small) functional effect of one gene may be obscured. Such a discrepancy in results has indeed been reported in a MRI-based study on brain volume (10/10 genotype at the 3 0 UTR VNTR showed smaller caudate nucleus volume only in non-affected siblings and not in affected subjects [Durston et al., 2005] ). Therefore, analyses were repeated separately for affected and non-affected siblings. Results revealed some nominal associations between DAT1 and the aggregated score of neuropsychological functioning in non-affected siblings and not in affected siblings. However, these were present only in children and appeared spurious (data not shown). Thus, the nonsignificant relation between DAT1 and the aggregated neuropsychological component reported in the main analyses was not likely due to a differential effect of DAT1 on neuropsychological functioning in affected and non-affected subjects.
Possibility 3: DAT1 is only associated with neuropsychological performance in subjects without conduct disorder and not in subjects with conduct disorder. Recently, in the larger IMAGE sample we demonstrated that the association between DAT1 and ADHD was only significant for subjects without conduct disorder as opposed to ADHD subjects with conduct disorder [Zhou et al., 2007] . Since the same may be true for the association between DAT1 and neuropsychological functioning, we repeated the analyses for subjects without possible conduct disorder (i.e., Conners' Oppositional Behavior T-score parents and teachers 75). A total of 109 affected siblings (from the original 350) and 10 non-affected siblings (from the original 195) were excluded from analyses. None of the DAT1 risk markers was associated with the aggregated neuropsychological component score, neither in the overall group nor in the separate subgroups of children and adolescents (data not shown).
DISCUSSION
A review of studies conducted thus far on the neurophysiological and neuropsychological effects of DAT1 in ADHD (see column 2 and Table I ) demonstrated inconsistent results. Most studies have compared the 10/10 genotype with other genotypes of this polymorphism in the 3 0 UTR and did not find differences in neurophysiological and neuropsychological measures. In some cases, ADHD patients with the 10/10 genotype performed worse than ADHD patients with other genotypes on measures of attentional asymmetry, response variability, vigilance and EEG activity in response to methylphenidate [Loo et al., 2003; Bellgrove et al., 2005a Bellgrove et al., ,b, 2007 . However, contrary findings have also been reported, in which ADHD patients with the 10/10 genotype performed better than ADHD patients with other genotypes [Oh et al., 2003; Kim et al., 2006; Boonstra et al., 2007] .
Our study aimed at examining the neuropsychological mechanisms of DAT1 in ADHD, improving upon previous studies with respect to sample size and sample composition, scope of the neuropsychological battery and number of genotyped polymorphisms in DAT1. The most important conclusion that can be drawn from our findings is that DAT1 is not associated with the neuropsychological measures used in this study, even though several risk markers of DAT1 were associated with ADHD in this sample and ADHD was strongly related to abnormal neuropsychological functioning. Even the subjects carrying the highest possible risk (2 risk diplotypes) did not differ neuropsychologically from subjects with other diplotypes. The absence of an effect of DAT1 on neuropsychological measures is in line with the majority of previous studies [Ball et al., 1998; Fossella et al., 2002; Oh et al., 2003; Rueda et al., 2005; Szobot et al., 2005; Barkley et al., 2006; Genro et al., 2006; Kim et al., 2006; Boonstra et al., 2007; Sonuga-Barke et al., 2008; Wohl et al., 2008; Loo et al., submitted] . It may, however, be hypothesized that DAT1 has an effect on neuropsychological processes not examined in this study or previous studies, like delay aversion. An altered delay aversion has been frequently found in ADHD, in which patients are more motivated to escape or avoid delay than controls [SonugaBarke, 2002] . This altered delay aversion appears not related to impaired executive/cognitive functions [Sonuga-Barke, 2002 Toplak et al., 2005] , but is related to reduced striatal activation [Scheres et al., 2007] . Since DAT1 is mainly expressed in the striatum and to a lesser degree in the prefrontal cortex [Durston et al., 2005; Schott et al., 2006; Diamond, 2007; Scherk et al., 2007] , DAT1 may have an effect on striatum related functions (like delay aversion and motor functions) rather than prefrontal related functions (like executive functions) [Sonuga-Barke, 2002] . The more detailed analysis of individual neuropsychological tests also supported this hypothesis: if there was any association between DAT1 and neuropsychological functioning in our sample, it was within the domain of motor functioning and not within the executive/cognitive domain.
We did not find differential effects of DAT1 on neuropsychological functioning after stratification of the sample into affected and non-affected siblings. An effect in non-affected siblings only, was previously found for DAT1 on the nucleus caudatus volume [Durston et al., 2005] and for the DRD4 gene on ADHD in our own studies [Altink et al., 2008] . We also did not find effects of DAT1 on neuropsychology after stratification according to the presence or absence of conduct disorder, an analysis inspired by our findings in the larger IMAGE sample that showed association of DAT1 with ADHD only in the absence of conduct disorder [Zhou et al., 2007] .
Interestingly, splitting the sample into children and adolescents resulted in nominally significant findings predominantly in the adolescent group. This may suggest that the effect of DAT1 on ADHD is not constant across development, but becomes apparent in late childhood and adolescence [Elia and Devoto, 2007] . This may be related to the finding that dopamine levels decrease with increasing age, resulting in a relatively larger effect of an ''overactive'' dopamine transporter on ADHD [Diamond, 2007] . Some support for this hypothesis has also been reported by Barkley et al. [2006] . They followed children through adolescence and later through adulthood and reported that the effect of DAT1 on phenotypic measures of ADHD increased substantially with increasing age. Given that the genotype did not differ between measurement moments in childhood, adolescence, and adulthood, the study of Barkley et al. [2006] provides preliminary evidence that the effect of DAT1 on ADHD may be stronger in older subjects with ADHD compared to younger subjects. However, an alternative explanation is also possible. It may be that adolescents and adults with ADHD carry a stronger genetic load or form a genetically more pure subgroup of ADHD patients than preadolescent children with ADHD. That is, having a persistent form of ADHD that continues into adolescence and adulthood may be more heavily related to genetic factors than a remitting form of ADHD [Faraone et al., 2000] .
Limitations
A limitation of this study was that we had SNP data available for only 63% of the sample (though 89% of the VNTR data was available). It could be argued that this may have a profound effect on the power of the study to detect effects of DAT1 and may explain the negative results of DAT1 on neuropsychological measures. However, if that would be true, then also no associations would be expected between the SNPs and ADHD. This was not the case, two SNPs were associated with ADHD. Moreover, in theory, the effect of DAT1 on neuropsychological functioning should be more readily detectable than the effect of DAT1 on ADHD: neuropsychological measures may act as endophenotypes, which are hypothesized as stronger linked to individual genes [Almasy and Blangero, 2001; Castellanos and Tannock, 2002] . It thus seems implausible that the absence of a relation between DAT1 and neuropsychological functioning was attributable to limited power. However, it may be feasible that DAT1 is associated either with other neuropsychological traits, or with neuropsychological functioning only in the presence of particular environmental conditions not accounted for in the current study. For example, it has been reported that DAT1 genotype only has an effect on ADHD symptomatology if the child was exposed to prenatal smoking or if the child grew up in the context of great psychosocial adversity [Laucht et al., 2007; Becker et al., 2008] . Not taking into account such moderating factors may explain the null findings in the review and analyses described in this article.
CONCLUSION
Several polymorphisms and haplotypes of DAT1 were associated with ADHD in this subsample of IMAGE. ADHD was also associated with abnormal neuropsychological functioning. In contrast, DAT1 had no relation to neuropsychological dysfunction. This suggests that the effect of DAT1 on the ADHD phenotype is not mediated by neuropsychological performance. However, since DAT1 is mainly expressed in the striatum and not the prefrontal cortex, DAT1 may influence striatum related functions (like delay aversion and motor functions) more heavily than prefrontal related functions (like executive functions). An effect of age seemed present with several DAT1 risk markers and diplotypes nominally associated with ADHD in adolescents. This suggests that the effect of DAT1 on ADHD is not constant across development, but only becomes apparent in adolescence, and/ or that having a persistent form of ADHD that continues into adolescence may mark a more severe or homogeneous genetic form of the disorder.
